Recap: Emergent BioSolutions Q1 Earnings

Comments
Loading...

Emergent BioSolutions EBS reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Emergent BioSolutions missed estimated earnings by 155.65%, reporting an EPS of $-3.17 versus an estimate of $-1.24.

Revenue was down $142.40 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.35 which was followed by a 11.57% drop in the share price the next day.

Here's a look at Emergent BioSolutions's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.04 -0.06 0.37 0.12
EPS Actual -0.31 -1.27 -0.86 0.18
Revenue Estimate 296.62M 268.30M 270.94M 283.00M
Revenue Actual 330.70M 240.00M 242.70M 307.50M

To track all earnings releases for Emergent BioSolutions visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!